Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Fibrinogen and the prediction of residual obstruction manifested after pulmonary embolism treatment.

Planquette B, Sanchez O, Marsh JJ, Chiles PG, Emmerich J, Le Gal G, Meyer G, Wolfson T, Gamst AC, Moore RE, Gugiu GB, Morris TA.

Eur Respir J. 2018 Nov 15;52(5). pii: 1801467. doi: 10.1183/13993003.01467-2018. Print 2018 Nov.

PMID:
30337447
2.

Chronic thromboembolic pulmonary hypertension-associated dysfibrinogenemias exhibit disorganized fibrin structure.

Marsh JJ, Chiles PG, Liang NC, Morris TA.

Thromb Res. 2013;132(6):729-34. doi: 10.1016/j.thromres.2013.09.024. Epub 2013 Sep 26.

PMID:
24182551
3.

Structural insights into fibrinogen dynamics using amide hydrogen/deuterium exchange mass spectrometry.

Marsh JJ, Guan HS, Li S, Chiles PG, Tran D, Morris TA.

Biochemistry. 2013 Aug 13;52(32):5491-502. doi: 10.1021/bi4007995. Epub 2013 Aug 2.

4.

Pilot study comparing SPECT perfusion scintigraphy with CT pulmonary angiography in chronic thromboembolic pulmonary hypertension.

Soler X, Kerr KM, Marsh JJ, Renner JW, Hoh CK, Test VJ, Morris TA.

Respirology. 2012 Jan;17(1):180-4. doi: 10.1111/j.1440-1843.2011.02061.x.

PMID:
21899658
5.

Efficacy of methylprednisolone in preventing lung injury following pulmonary thromboendarterectomy.

Kerr KM, Auger WR, Marsh JJ, Devendra G, Spragg RG, Kim NH, Channick RN, Jamieson SW, Madani MM, Manecke GR, Roth DM, Shragg GP, Fedullo PF.

Chest. 2012 Jan;141(1):27-35. doi: 10.1378/chest.10-2639. Epub 2011 Aug 11.

6.

Single photon emission computed tomography in chronic thromboembolic pulmonary hypertension.

Soler X, Hoh CK, Test VJ, Kerr KM, Marsh JJ, Morris TA.

Respirology. 2011 Jan;16(1):131-7. doi: 10.1111/j.1440-1843.2010.01867.x.

PMID:
20920137
7.

High prevalence of dysfibrinogenemia among patients with chronic thromboembolic pulmonary hypertension.

Morris TA, Marsh JJ, Chiles PG, Magaña MM, Liang NC, Soler X, Desantis DJ, Ngo D, Woods VL Jr.

Blood. 2009 Aug 27;114(9):1929-36. doi: 10.1182/blood-2009-03-208264. Epub 2009 May 6.

8.

Chronic exposure to fibrin and fibrinogen differentially regulates intracellular Ca2+ in human pulmonary arterial smooth muscle and endothelial cells.

Firth AL, Yau J, White A, Chiles PG, Marsh JJ, Morris TA, Yuan JX.

Am J Physiol Lung Cell Mol Physiol. 2009 Jun;296(6):L979-86. doi: 10.1152/ajplung.90412.2008. Epub 2009 Apr 10.

9.

Abnormally sialylated fibrinogen gamma-chains in a patient with chronic thromboembolic pulmonary hypertension.

Morris TA, Marsh JJ, Chiles PG, Kim NH, Noskovack KJ, Magana MM, Gruppo RA, Woods VL Jr.

Thromb Res. 2007;119(2):257-9. Epub 2006 Apr 19. No abstract available.

PMID:
16626789
10.

Fibrin derived from patients with chronic thromboembolic pulmonary hypertension is resistant to lysis.

Morris TA, Marsh JJ, Chiles PG, Auger WR, Fedullo PF, Woods VL Jr.

Am J Respir Crit Care Med. 2006 Jun 1;173(11):1270-5. Epub 2006 Mar 2.

11.

Pharmacokinetics of UH and LMWH are similar with respect to antithrombin activity.

Morris TA, Jacobson A, Marsh JJ, Lane JR.

Thromb Res. 2005;115(1-2):45-51.

PMID:
15567452
12.

Improved imaging of deep venous thrombi during anticoagulation using radiolabelled anti-D-dimer antibodies.

Morris TA, Marsh JJ, Konopka R, Pedersen CA, Chiles PG.

Nucl Med Commun. 2004 Sep;25(9):917-22.

PMID:
15319597
13.

Embolization itself stimulates thrombus propagation in pulmonary embolism.

Morris TA, Marsh JJ, Chiles PG, Pedersen CA, Konopka RG, Gamst AC, Loza O.

Am J Physiol Heart Circ Physiol. 2004 Aug;287(2):H818-22. Epub 2004 Mar 25.

14.

Single photon emission computed tomography of pulmonary emboli and venous thrombi using anti-D-dimer.

Morris TA, Marsh JJ, Chiles PG, Konopka RG, Pedersen CA, Schmidt PF, Gerometta M.

Am J Respir Crit Care Med. 2004 May 1;169(9):987-93. Epub 2004 Feb 12.

PMID:
14962817
15.

Surfactant from diving aquatic mammals.

Spragg RG, Ponganis PJ, Marsh JJ, Rau GA, Bernhard W.

J Appl Physiol (1985). 2004 May;96(5):1626-32. Epub 2003 Dec 19.

16.

Urine and plasma levels of fibrinopeptide B in patients with deep vein thrombosis and pulmonary embolism.

Morris TA, Marsh JJ, Burrows CM, Chiles PG, Konopka RG, Pedersen CA.

Thromb Res. 2003 May 1;110(2-3):159-65.

PMID:
12893031
17.

Treatment of acute respiratory distress syndrome with recombinant surfactant protein C surfactant.

Spragg RG, Lewis JF, Wurst W, Häfner D, Baughman RP, Wewers MD, Marsh JJ.

Am J Respir Crit Care Med. 2003 Jun 1;167(11):1562-6. Epub 2003 Mar 20.

PMID:
12649125
18.

Effect of CTP:phosphocholine cytidylyltransferase overexpression on the mouse lung surfactant system.

Li J, Marsh JJ, Spragg RG.

Am J Respir Cell Mol Biol. 2002 Jun;26(6):709-15.

PMID:
12034570
19.

Anti-thrombotic efficacies of enoxaparin, dalteparin, and unfractionated heparin in venous thrombo-embolism.

Morris TA, Marsh JJ, Konopka R, Pedersen CA, Chiles PG.

Thromb Res. 2000 Nov 1;100(3):185-94.

PMID:
11108906
20.

Pulmonary vascular remodeling distal to pulmonary artery ligation is accompanied by upregulation of endothelin receptors and nitric oxide synthase.

Kim H, Yung GL, Marsh JJ, Konopka RG, Pedersen CA, Chiles PG, Morris TA, Channick RN.

Exp Lung Res. 2000 Jun;26(4):287-301. Erratum in: Exp Lung Res 2000 Oct-Nov;26(7):565.

PMID:
10923246
21.

The use of cylexin (CY-1503) in prevention of reperfusion lung injury in patients undergoing pulmonary thromboendarterectomy.

Kerr KM, Auger WR, Marsh JJ, Comito RM, Fedullo RL, Smits GJ, Kapelanski DP, Fedullo PF, Channick RN, Jamieson SW, Moser KM.

Am J Respir Crit Care Med. 2000 Jul;162(1):14-20.

PMID:
10903213
22.

Endothelin mediates pulmonary vascular remodelling in a canine model of chronic embolic pulmonary hypertension.

Kim H, Yung GL, Marsh JJ, Konopka RG, Pedersen CA, Chiles PG, Morris TA, Channick RN.

Eur Respir J. 2000 Apr;15(4):640-8.

23.

Antibodies against the fibrin beta-chain amino-terminus detect active canine venous thrombi.

Morris TA, Marsh JJ, Konopka R, Pedersen CA, Chiles PG, Fagnani R, Hagan M, Moser KM.

Circulation. 1997 Nov 4;96(9):3173-9.

PMID:
9386190
24.

Degree of polymer organization decreases the binding of a monoclonal antibody raised against the beta-chain amino terminus of fibrin.

Morris TA, Marsh JJ, Fagnani R, Hagan M, Moser KM.

Thromb Haemost. 1997 Apr;77(4):704-9.

PMID:
9134647
25.

Suppression of thrombolysis in a canine model of pulmonary embolism.

Marsh JJ, Konopka RG, Lang IM, Wang HY, Pedersen C, Chiles P, Reilly CF, Moser KM.

Circulation. 1994 Dec;90(6):3091-7.

PMID:
7994858
27.

Expression of type 1 plasminogen activator inhibitor in chronic pulmonary thromboemboli.

Lang IM, Marsh JJ, Olman MA, Moser KM, Loskutoff DJ, Schleef RR.

Circulation. 1994 Jun;89(6):2715-21.

PMID:
8205686
28.

Validation of the Rockport Fitness Walking Test in college males and females.

Dolgener FA, Hensley LD, Marsh JJ, Fjelstul JK.

Res Q Exerc Sport. 1994 Jun;65(2):152-8.

PMID:
8047707
29.

Factors contributing to increased vascular fibrinolytic activity in mongrel dogs.

Lang IM, Marsh JJ, Konopka RG, Olman MA, Binder BR, Moser KM, Schleef RR.

Circulation. 1993 Jun;87(6):1990-2000.

PMID:
8504514
30.

Presence of active and latent type 1 plasminogen activator inhibitor associated with porcine platelets.

Lang IM, Marsh JJ, Moser KM, Schleef RR.

Blood. 1992 Nov 1;80(9):2269-74.

PMID:
1421397
31.

Endogenous fibrinolytic system in chronic large-vessel thromboembolic pulmonary hypertension.

Olman MA, Marsh JJ, Lang IM, Moser KM, Binder BR, Schleef RR.

Circulation. 1992 Oct;86(4):1241-8.

PMID:
1394930
32.

Fructose-bisphosphate aldolases: an evolutionary history.

Marsh JJ, Lebherz HG.

Trends Biochem Sci. 1992 Mar;17(3):110-3. Review.

PMID:
1412694
33.

Chronic pulmonary thromboembolism in dogs treated with tranexamic acid.

Moser KM, Cantor JP, Olman M, Villespin I, Graif JL, Konopka R, Marsh JJ, Pedersen C.

Circulation. 1991 Apr;83(4):1371-9.

PMID:
2013154
35.

Planning and implementing a hospital information system.

Anneren MR, Marsh JJ, Kendrick P.

Nurs Adm Q. 1986 Winter;10(2):39-46. No abstract available.

PMID:
3513064
36.

Implementation of a model for census prediction and control.

Swain RW, Kilpatrick KE, Marsh JJ 3rd.

Health Serv Res. 1977 Winter;12(4):380-95.

37.

Confirmation by synthesis of ristosamine as 3-amino-2,3,6-trideoxy-L-ribo-hexose.

Lee WW, Wu HY, Marsh JJ Jr, Mosher CW, Acton EM, Goodman L, Henry DW.

J Med Chem. 1975 Jul;18(7):767-8. No abstract available.

PMID:
168386

Supplemental Content

Loading ...
Support Center